Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(s)-camptothecin
2. Gg-211
3. Gg211
4. Gi 147211
5. Gi-147211
6. Gi147211
7. Gl 147211c
8. Gl-147211c
9. Gl147211c
10. Nx 211
11. Nx-211
12. Nx211 Cpd
13. Osi 211
14. Osi-211
15. Osi211
1. 149882-10-0
2. Osi-211
3. Lurtotecan [inn]
4. 4j1l80t08i
5. Gg-211
6. Nx-211
7. Gi-147211
8. Gg 211; Gi 147211; Lurtotecan; Nx 211; Osi 211
9. Chembl341028
10. (s)-8-ethyl-8-hydroxy-15-((4-methylpiperazin-1-yl)methyl)-11,14-dihydro-2h-[1,4]dioxino[2,3-g]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9,12(3h,8h)-dione
11. Osi 211
12. Gg 211
13. Nx 211
14. Gi 147211
15. Unii-4j1l80t08i
16. Nx211 Cpd
17. Lurtotecan [who-dd]
18. Schembl19208
19. Chembl305666
20. Osi211
21. Dtxsid30164422
22. Gg211
23. Gl147211c
24. Gl 147211c
25. Bdbm50036130
26. Gw-211
27. Zinc22010625
28. Db12222
29. Gl-147211c
30. 11h-1,4-dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8h,14h)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (8s)-
31. Gi147211
32. Hy-13670
33. Cs-0007547
34. A936765
35. Q6704977
36. D-myo-inositol2,4,5-trisphosphate,hexaammoniumsalt
37. 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(s)-camptothecin
38. (18s)-18-ethyl-18-hydroxy-2-[(4-methylpiperazin-1-yl)methyl]-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.03,12.05,10.015,24.017,22]pentacosa-1,3,5(10),11,13,15,17(22)-heptaene-19,23-dione
39. (8s)-8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-11h-p-dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8h,14h)-dione
40. (s)-8-ethyl-8-hydroxy-15-((4-methylpiperazin-1-yl)methyl)-2,3,11,14-tetrahydro-12h-[1,4]dioxino[2,3-g]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9,12(8h)-dione
41. 11h-1,4-dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8h,14h)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (s)
42. 8-ethyl-8-hydroxy-15-(4-methylhexahydro-1-pyrazinylmethyl)-(8s)-2,3,8,9,12,14-hexahydro-11h-[1,4]dioxino[2,3-g]pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-9,12-dione With Trifluoroaceticacid
Molecular Weight | 518.6 g/mol |
---|---|
Molecular Formula | C28H30N4O6 |
XLogP3 | 0.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Exact Mass | 518.21653469 g/mol |
Monoisotopic Mass | 518.21653469 g/mol |
Topological Polar Surface Area | 105 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 1070 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
29
PharmaCompass offers a list of Lurtotecan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lurtotecan manufacturer or Lurtotecan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lurtotecan manufacturer or Lurtotecan supplier.
PharmaCompass also assists you with knowing the Lurtotecan API Price utilized in the formulation of products. Lurtotecan API Price is not always fixed or binding as the Lurtotecan Price is obtained through a variety of data sources. The Lurtotecan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GG 211 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GG 211, including repackagers and relabelers. The FDA regulates GG 211 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GG 211 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GG 211 supplier is an individual or a company that provides GG 211 active pharmaceutical ingredient (API) or GG 211 finished formulations upon request. The GG 211 suppliers may include GG 211 API manufacturers, exporters, distributors and traders.
click here to find a list of GG 211 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A GG 211 DMF (Drug Master File) is a document detailing the whole manufacturing process of GG 211 active pharmaceutical ingredient (API) in detail. Different forms of GG 211 DMFs exist exist since differing nations have different regulations, such as GG 211 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A GG 211 DMF submitted to regulatory agencies in the US is known as a USDMF. GG 211 USDMF includes data on GG 211's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The GG 211 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of GG 211 suppliers with USDMF on PharmaCompass.
GG 211 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GG 211 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GG 211 GMP manufacturer or GG 211 GMP API supplier for your needs.
A GG 211 CoA (Certificate of Analysis) is a formal document that attests to GG 211's compliance with GG 211 specifications and serves as a tool for batch-level quality control.
GG 211 CoA mostly includes findings from lab analyses of a specific batch. For each GG 211 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GG 211 may be tested according to a variety of international standards, such as European Pharmacopoeia (GG 211 EP), GG 211 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GG 211 USP).